For Immediate Release
Chicago, IL – January 3, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc.
AAPL
, Johnson & Johnson
JNJ
, CSX Corp.
CSX
, American International Group, Inc.
AIG
and CenterPoint Energy, Inc.
CNP
.
Here are highlights from Friday’s Analyst Blog:
Earnings Outlook for 2023, and Featured Reports for Apple, J&J and Others
The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features an update on the evolving earnings picture for 2023 and new research reports on 16 major stocks, including Apple Inc., Johnson & Johnson and CSX Corp. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can
see all of today’s research reports here >>>
Earnings Outlook for 2023
Multiple forces are at play in driving stock prices at any point in time. But the two biggest forces in the long run are interest rates and corporate earnings, with our focus in this note solely on the earnings part.
Aggregate bottom-up earnings for the S&P 500 index are currently expected to be up +2.2% in 2023 on +2.1% higher revenues. This would follow the +4.7% earnings growth in 2022 on +10.6% higher revenues.
Estimates for 2023 have been steadily coming down, after peaking in mid-April 2022. In the aggregate, S&P 500 earnings estimates have declined by -9.4% since mid-April for the index as a whole and -11.8% excluding the Energy sector.
Estimates have been cut for 12 of the 16 Zacks sectors, with the biggest cuts to estimates for the Construction (Negative revision of -29.6% since mid-April), Consumer Discretionary (-21.5%), Retail (-21.2%), Tech (-19.6%), Industrials (-13.8%), Aerospace (-13.7%), and Transportation (-10.2%). Estimates for Energy, Utilities, Autos and Basic Materials have modestly increased.
The future course of revisions will depend on how the underlying economic outlook unfolds in response to the Fed tightening cycle.
I am of the opinion that a relatively benign outcome for the U.S. economy where it is able to dodge a nasty recession will be consistent with an earnings outlook that is roughly in-line with current earnings estimates.
I am not suggesting that estimates do not need to come down further. But rather than aggregate estimates outside of the Energy sector already down by almost -12% since mid-April, there may not be a whole lot of further room to fall as long as the economic outlook doesn’t materially deteriorate.
Today’s Featured Research Reports
Shares of
Apple
have declined -27.9% over the past year against the Zacks Tech sector’s decline of -37.3% and the S&P 500 index’s -20.9% pullback. The Zacks analyst believes that Apple’s holiday season iPhone shipments are expected to suffer from disruptions at its Chinese partner Foxconn’s factory in Zhengzhou. We expect Apple to ship roughly 70 million iPhones in the first quarter of fiscal 2023.
The company expects year-over-year revenue growth to decelerate in the fiscal first quarter compared with the fiscal fourth quarter due to unfavorable forex. Mac revenues are expected to be negatively impacted by forex. Apple expects Mac revenues to decline substantially year over year during the December quarter.
Services revenue growth is expected to be negatively impacted by challenging macroeconomic conditions, unfavorable forex, as well as weakness in digital advertising and gaming. Nevertheless, a growing subscriber base in the Services business and a strong liquidity position are key catalysts.
(You can
read the full research report on Apple here >>>
)
Shares of
Johnson & Johnson
have gained +3.1% over the past year against the Zacks Large Cap Pharmaceuticals industry’s gain of +12.3%. The Zacks analyst believes that J&J’s sales in the MedTech unit are recovering and the company is focusing on growing this business through new products. J&J is making rapid progress with its pipeline and line extensions.
However, macroeconomic headwinds like inflationary pressure, rising input costs and negative currency impact are hurting margins. Headwinds like generic competition and pricing pressure continue. Stelara’s upcoming loss of exclusivity in 2023 is a concern. Though J&J has taken meaningful steps to resolve its talc and opioid litigation, they continue to remain an overhang on the stock.
(You can
read the full research report on Johnson & Johnson here >>>
)
CSX
shares have outperformed the Zacks Transportation – Rail industry over the past six months (+6.5% vs. +3.5%). The Zacks analyst believes that CSX is benefiting from higher export coal volumes, domestic intermodal shipments and favorable pricing. With the demand scenario expected to remain strong, despite the current market bloodbath, management anticipates double-digit growth in operating income and revenues for 2022 from 2021’s reported levels.
However, supply-chain disturbances are hurting CSX’s operations. Weakness in the merchandise segment due to lower volumes of fertilizers is concerning. High costs, primarily due to escalating fuel expenses, pose a threat to CSX’s bottom line. High capital expenditures are also worrisome.
(You can
read the full research report on CSX here >>>
)
Other noteworthy reports we are featuring today include American International Group, Inc. and CenterPoint Energy, Inc.
Why Haven’t You Looked at Zacks’ Top Stocks?
Our 5 best-performing strategies have blown away the S&P’s impressive +28.8% gain in 2021. Amazingly, they soared
+40.3%, +48.2%, +67.6%, +94.4%,
and
+95.3%
. Today you can access their live picks without cost or obligation.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss
.
This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit
https://www.zacks.com/performance
for information about the performance numbers displayed in this press release.
Zacks Top 10 Stocks for 2023
In addition to the investment ideas discussed above, would you like to know about our 10 top picks for the entirety of 2023? From inception in 2012 through November, the
Zacks Top 10 Stocks
portfolio has tripled the market, gaining an impressive +884.5% versus the S&P 500’s +287.4%.
Now our Director of Research is combing through 4,000 companies covered by the Zacks Rank to handpick the best 10 tickers to buy and hold. Don’t miss your chance to get in on these stocks when they’re released on January 3.
Be First to New Top 10 Stocks >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
